(4.39)
Based on 7 studies
| Side Effect | Affected |
|---|---|
| Application site reactions | 3% |
| Skin dryness | |
| Itching at application site |
Image for illustration purposes only. Actual medication may appear different.
Get Halobetasol
Consult with a board-certified medical professional
Image for illustration purposes only. Actual medication may appear different.
Highlights
- Success rates of 88-94% in treating eczema
- Fast-acting with improvements seen within 3 days
- Highly effective when used as cream/ointment combination
- Low rate of side effects (2-5% of patients)
- Can cause skin dryness, itching, or burning at application site
- Potential for skin thinning with prolonged use
Halobetasol is highly effective at treating eczema, with success rates between 88-94% across multiple studies. Most patients see significant improvement or complete healing of their eczema.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
|
Clinical Trial |
Total Patients: 264
Severity: severe Age: Not specified
|
All three treatments showed similar high success rates |
|
📄
Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
|
Clinical Trial |
Total Patients: 120
|
Halobetasol propionate showed better overall success rate |
Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitisHalobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicusThe medication works quickly, with many patients seeing improvements within the first 3 days of treatment. This fast action makes it particularly useful for quick relief of symptoms.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
|
Clinical Trial |
Total Patients: 120
|
Halobetasol propionate showed better overall success rate |
|
📄
Halobetasol propionate 0.05% ointment was significantly more effective than vehicle (placebo) in treating eczema. After 2 weeks of treatment, 83% of patients using halobetasol showed complete or marked improvement compared to 28% using vehicle. The medication was well-tolerated with no skin thinning reported.
|
Clinical Trial |
Total Patients: 224
|
Halobetasol was significantly more effective than vehicle in treating chronic eczema |
Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicusHalobetasol propionate 0.05% ointment was significantly more effective than vehicle (placebo) in treating eczema. After 2 weeks of treatment, 83% of patients using halobetasol showed complete or marked improvement compared to 28% using vehicle. The medication was well-tolerated with no skin thinning reported.
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatosesHalobetasol is generally safe and well-tolerated. Side effects are uncommon (occurring in only 2-5% of patients) and usually mild, mainly including skin dryness, itching, or burning sensations at the application site.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
|
Clinical Trial |
Total Patients: 264
Severity: severe Age: Not specified
|
All three treatments showed similar high success rates |
|
📄
Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The cream improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.
|
Clinical Trial |
Total Patients: 111
Severity: Chronic Age: Not specified
|
Significant improvement in all symptoms compared to vehicle (p<0.001) |
Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitisHalobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The cream improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.
Double-blind bilateral paired comparison of 0.05% halobetasol propionate cream and its vehicle in patients with chronic atopic dermatitis and other eczematous dermatosesThe medication is available in both cream and ointment forms, and can be effective in both adults and children. In pediatric patients, it showed excellent results with 100% success rate for eczema treatment.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
|
Clinical Trial |
Total Patients: 264
Severity: severe Age: Not specified
|
All three treatments showed similar high success rates |
Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitisHalobetasol propionate is highly effective at treating eczema, with success rates (defined as 'healed' or 'marked improvement') ranging from 88% to 94% in various studies. It starts working quickly, with many patients seeing improvement within 3 days of starting treatment.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
|
Clinical Trial |
Total Patients: 264
Severity: severe Age: Not available
|
All three treatments showed similar high effectiveness |
|
📄
Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
|
Clinical Trial |
Total Patients: 120
|
Halobetasol propionate showed better overall success rate |
Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitisHalobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicusThe medication is generally well-tolerated with a low rate of side effects (2-5% of patients). The most common side effects are skin dryness, itching, or burning at the application site.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
|
Clinical Trial |
Total Patients: 264
Severity: severe Age: Not available
|
All three treatments showed similar high effectiveness |
|
📄
Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The medication improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.
|
Clinical Trial |
Total Patients: 111
|
Significant improvement in all symptoms compared to vehicle by day 7 and day 14 (p<0.001) |
Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitisHalobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The medication improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.
Double-blind bilateral paired comparison of 0.05% halobetasol propionate cream and its vehicle in patients with chronic atopic dermatitis and other eczematous dermatosesIn children with severe eczema, the combination of halobetasol propionate cream during the day and ointment at night was extremely effective, with a 100% success rate. However, careful monitoring is needed as one case of mild skin thinning was reported.
| Study Summary | Study Type | Studied Population | Results |
|---|
The medication performs as well as or better than other strong topical steroids like clobetasol propionate and betamethasone dipropionate, making it a reliable option for treating severe eczema.
| Study Summary | Study Type | Studied Population | Results |
|---|---|---|---|
|
📄
Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
|
Clinical Trial |
Total Patients: 264
Severity: severe Age: Not available
|
All three treatments showed similar high effectiveness |
|
📄
Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
|
Clinical Trial |
Total Patients: 120
|
Halobetasol propionate showed better overall success rate |
Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitisHalobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicusIs Halobetasol Right For Me?
-
You have inflammatory skin conditions that respond to corticosteroids
-
You are 12 years or older
-
You need treatment for no longer than 2 weeks
-
You will not use more than 50g per week
Interested in eczema products?
As a member of the Lemma Health community, you'll stay up to date with research, hear about new products, and get exclusive access to discounts.
Personalized Eczema Care—Powered by AI
AI that understands your skin
Our AI learns from your symptoms, triggers, and lifestyle to recommend treatments tailored to you. As your skin changes, your plan adapts—for lasting relief.
Data-backed suggestions in seconds
Instantly analyzes real-world reviews and clinical research to skip months of trial and error. Get trusted, proven treatment ideas—fast.
Doctors who listen—and move fast
You’re in control. Found a treatment that resonates? We’ll connect you to a dermatologist who respects your plan and helps you get care from home.
How Lemma Health Works
Get Smart, Personalized Recommendations
Skip the guesswork
Our AI reviews thousands of research studies and real-world results to match you with the most effective treatments for your unique skin profile.
Talk to a Dermatologist who Listens — Fast
Found something you want to try?
We’ll connect you with a board-certified dermatologist who respects your preferences and helps you get what you need without the wait.
Let AI Fine-Tune Your Plan Over Time
Eczema isn’t static—
and neither is our support
As you log what’s working (or not), our AI adapts your plan to keep improving it. We help you adjust, optimize, and stay ahead of flare-ups.
Your Skin Will Thank You
Take our 2-minute profile quiz and see what’s working for people just like you.
What are others saying?
The following comments are sourced from publicly available forums, including Reddit. They reflect personal opinions and anecdotal experiences, and do not constitute medical advice. Lemma Health does not verify the accuracy, completeness, or authorship of these statements, nor does it endorse any specific treatment, medication, or outcome mentioned. These excerpts are provided for informational purposes only.
No reviews available yet
We collect reviews of treatments from various sources including social media and are not always able to verify whether these have been written by actual patients.